Last reviewed · How we verify

NCT05403216

Relationship Between Oral Lichen Planus and Autoimmune Thyroid Diseases

Completed Last updated 25 September 2025
What this trial tests

trial testing no intervention in Oral Lichen Planus in 150 participants. Completed in 31 December 2024.

Timeline
1 December 2022
Primary endpoint
31 December 2024
31 December 2024

Quick facts

Lead sponsorThe Dental Hospital of Zhejiang University School of Medicine
StatusCompleted
Study typeOBSERVATIONAL
Enrollment150
Start date1 December 2022
Primary completion31 December 2024
Estimated completion31 December 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

The Dental Hospital of Zhejiang University School of Medicine

Who can join

Adults 18 to 65, any sex, with Oral Lichen Planus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

On the basis of previous studies, a validation cohort will be established to explore the relationship between oral lichen planus and autoimmune thyroid diseases, and a disease efficacy prediction strategy can be formed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of no intervention

Trials testing the same drug.

Other recruiting trials for Oral Lichen Planus

Currently open trials in the same condition.

Other The Dental Hospital of Zhejiang University School of Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05403216.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing